Text Size:

A A A

Contrast:

Research and Clinical Trial Services

research website banner 3994x1249

Asian Eye Institute is committed in improving the overall health of populations in the Philippines and the Asia-Pacific Region through research and innovation. Since 2002, Asian Eye doctors have been collaborating with pharmaceutical and biotech companies to discover new medical solutions and provide patients with innovative and excellent care.

With over 116 clinical trials and investigator-led researches, Asian Eye has become one of the leading sites in Asia for testing latest medicines and ophthalmic devices. Drugs like Retisert, Ozurdex and Simbrinza are now available in the market. Asian Eye is also home to pioneering treatments and technology, such as:

  • Victus Femtolaser – a laser treatment that makes cataract surgery faster, more precise and more comfortable
  • Supracor – a laser treatment that restores both near and intermediate vision
  • Selective laser trabeculoplasty – treatment for advanced glaucoma
  • Sutureless vitrectomy – a retina procedure that significantly reduces operating time and post-operation discomfort

As leaders of eye care innovation, Asian Eye has produced numerous international publications that have served as reference for local and international doctors in treating their own patients. Its doctors have also been recognized by prestigious organizations, such as the Philippine Academy of Ophthalmology (PAO), American Society of Cataract and Refractive Surgery (ASCRS), Asia-Pacific Academy of Ophthalmology (APAO) and Asia-Pacific Association of Cataract and Refractive Surgery (APACRS).

In 2014, it started conducting non-eye health related researches – from development of study proposal, conducting of research, collection and analysis of data to development of report.

Find out more about our clinical research. You may get in touch with Mary Ann Catacutan through MTCatacutan@asianeyeinstitute.com or 898-2020 local 109.